GHGolnaz Houshmand

Golnaz Houshmand

*This is an algorithmically generated author record based on publicly available information.

Golnaz Houshmand has a total of 200 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fibrosis location, fibrosis burden, and myocardial strain in patients with non-ischemic dilated cardiomyopathy: association with adverse clinical outcomes

    by Bahareh Jahanshahi, Saeed Ghodsi, Pooya Eini, Faezeh Tabesh, Saeideh Mazloomzadeh, Nasim Naderi, Marzieh Motevali, Hamidreza Pouraliakbar, Golnaz Houshmand

  • Open Access

    CT mitral valve calcium score and immediate outcomes after percutaneous transvenous mitral commissurotomy

    by Pooya Eini, Amir Ghaffari Jolfayi, Ata Firouzi, Farnaz Rafiee, Behnam Ranjbar, Raheleh Kaviani, Mozhgan Parsaee, Mohammad Javad Alemzadeh-Ansari, Hooman Bakhshandeh, Majid Maleki, et al.

  • Open Access

    Investigating the Short‐Term Changes of the Electrocardiogram Indicators During Hospitalization in Patients With COVID‐19 Following the Use of Tocilizumab

    by Mahdi Zahedi, Golnaz Houshmand, Tabassom Hosseini

    Objectives: To evaluate short‐term changes in electrocardiographic (ECG) parameters after tocilizumab administration in COVID‐19 patients, considering the drug's role in treating severe cases and the involvement of IL‐6 in cardiovascular effects and ECG alterations. Methods: In this retrospective study, we assessed cardiovascular and electrocardiographic parameters in PCR‐confirmed COVID‐19 patients who received tocilizumab. ECG variables were evaluated at two time points: 24 h before and 24 h after drug administration. All ECGs were verified by a supervisor, and demographic information was extracted from patient records. Results: 33 patients were included, of whom 36.4% were men. The patients' ages ranged from 37 to 79 years. The corrected QT interval (QTc) measured 24 h before (QTc1) and 24 h after (QTc2) tocilizumab administration showed no significant difference (QTc1: 390.3 ± 31.67 ms; QTc2: 392.73 ± 36.68 ms). No significant ECG changes were observed in the ST segment, ventricular fibrillation (VF), ventricular tachycardia (VT), or atrial fibrillation (AF). Four patients experienced cardiorespiratory arrest within 24 h after receiving tocilizumab. Conclusion: Tocilizumab administration in critically ill COVID‐19 patients was not associated with significant short‐term ECG changes or specific cardiovascular complications. Although previous studies in inflammatory diseases such as rheumatoid arthritis have reported QTc shortening following tocilizumab treatment, likely through suppression of IL‐6‐mediated systemic inflammation, no significant QTc reduction was observed in our cohort during the 24‐h follow‐up period. A few cases of cardiorespiratory arrest occurred; a causal relationship with tocilizumab could not be established due to the severity of illness and limited clinical data.

  • Open Access

    Left main coronary artery stenosis assessment on coronary CT angiography

    by Mahdi Zahedi, Pooya Eini, Mohammad Javad Alemzadeh-Ansari, Marzieh Motevalli, Amirafraz Fallah Najmabadi, Golnaz Houshmand

  • Open Access

    Heart failure in a 10-year-old girl: incidental discovery of adrenal adenoma by cardiac MRI—case report

    by Pooya Eini, Mohammad Mahdavi, Zahra Ghaemmaghami, Hamidreza Pouraliakbar, Golnaz Houshmand

    Background: Functional adrenal adenoma is uncommon in children, and cardiovascular complications, such as dilated cardiomyopathy and heart failure (HF), are rare as initial manifestations. Case summary: Here, we report a 10-year-old girl presenting with acute HF, mild troponin rise and severe left ventricular dysfunction in echocardiography. The Cardiac magnetic resonance imaging (CMR) demonstrated dilated cardiomyopathy, with a left ventricular ejection fraction (LVEF) of 17% with concentric left ventricular hypertrophy and a focal myocardial infarction. Extracardiac findings in CMR showed an incidental 3-cm right adrenal mass, and subsequent dedicated MRI with adrenal protocol showed features of a benign adenoma. Laboratory findings showed mixed Cushing's and hyperaldosteronism suggestive of a functional adrenal adenoma. The radical right adrenalectomy was performed, and pathology confirmed the diagnosis. Discussion: In the 1-year follow-up echocardiography, the LVEF was back to normal (55%), highlighting the reversible nature of cardiomyopathy in this condition.

  • Open Access

    “Severe Aortic Regurgitation as the Initial Manifestation of Takayasu Arteritis in a Young Woman: A Case Report”

    by Amir Heidari, Azar Nejati, S. Enssieh Hashemi, Mohammad Javad Bahadori, Golnaz Houshmand, Amin Fath Tabar

    Takayasu arteritis (TAK) is a rare large‐vessel vasculitis primarily affecting young women, characterized by idiopathic inflammation of the aorta and its major branches. While aortic regurgitation (AR) is a recognized complication, it typically occurs in advanced disease stages. Isolated severe AR as the initial manifestation is exceptionally uncommon and poses diagnostic challenges. We present a 39‐year‐old woman with no prior medical history who presented with progressive exertional dyspnea (NYHA Class II) and exertional chest pain. Physical examination revealed absent upper limb pulses, unmeasurable brachial blood pressure, and a diastolic murmur. Transthoracic echocardiography demonstrated severe AR with left ventricular dysfunction (EF 48%). CT and MR angiography confirmed circumferential aortic wall thickening, subclavian artery occlusions, and ostial right coronary artery stenosis. Elevated inflammatory markers (ESR and CRP) and vascular imaging findings established the diagnosis of TAK based on the 1996 Modified Ishikawa Criteria. Initial treatment included high‐dose glucocorticoids and methotrexate for disease control. Due to persistent severe AR, the patient underwent successful mechanical aortic valve replacement. Postoperative recovery was uncomplicated, with significant clinical improvement at 1‐year follow‐up and no disease recurrence. This case illustrates that severe AR can rarely serve as the initial manifestation of TAK, emphasizing the importance of considering large‐vessel vasculitis in young patients with unexplained valvulopathy and systemic inflammation. Early diagnosis, combined medical‐surgical management, and careful long‐term monitoring are essential for optimizing outcomes in this high‐risk population.

  • Open Access

    Evaluation of Aortic Dilation in Patients With Hypertrophic Cardiomyopathy in a Tertiary Center for Cardiovascular Disease

    by Tahereh Babaei, Kosar Babaei, Golnaz Houshmand, Farzaneh Amini, Parham Rabiee, Zeinab Norouzi, Hamideh Khesali, Raheleh Kaviani

    Background: Hypertrophic cardiomyopathy (HCM) is a common genetic cardiac disease primarily affecting the left ventricle. While the disease is traditionally associated with myocardial hypertrophy and left ventricular outflow tract (LVOT) obstruction, aortic dilation has emerged as a potentially serious but underrecognized complication. This study aimed to determine the prevalence of aortic dilation in HCM patients and to identify associated clinical and echocardiographic factors. Methods: In this cross‐sectional, retrospective study, 216 adult patients diagnosed with HCM at Rajaie Cardiovascular Institute (Tehran, Iran) from 2016 to 2021 were evaluated. Patients with significant valvular disease, congenital aortic anomalies, prior aortic surgery, or other cardiomyopathies were excluded. Clinical data and echocardiographic measurements, including aortic dimensions indexed to body surface area (BSA), were collected. Cardiac magnetic resonance imaging (MRI) data of myocardial fibrosis were also assessed in a subset of patients. Logistic regression was used to identify factors independently associated with aortic dilation. Results: Dilated ascending aorta was present in 56 patients (26.3%), while 12 patients (5.6%) had dilation of the sinus of Valsalva (SOV). Dilated ascending aorta was significantly associated with older age ( p = 0.001), hypertension ( p = 0.001), and increased BSA ( p = 0.002). LV end‐systolic diameter (LVESD) also showed a significant correlation ( p = 0.002). Multivariate analysis identified age (OR = 1.063), hypertension (OR = 5.49), LVESD (OR = 3.25), and right ventricular hypertrophy (OR = 4.99) as independent predictors of ascending aorta dilation. SOV dilation was similarly associated with age (OR = 1.117) and lower weight (OR = 0.915). Although myocardial fibrosis was more common in patients with ascending aorta dilation, this did not reach statistical significance ( p = 0.006). Conclusion: Aortic dilation is a relatively common finding in patients with HCM and is significantly associated with age, hypertension, and structural cardiac remodeling. Routine evaluation of the ascending aorta and SOV in HCM patients may aid in the early detection and management of this potential complication.

  • Open Access

    Applicability of Stress Cardiac Magnetic Resonance Imaging in Patients With Cardiac Implantable Devices: A Systematic Review

    by Sarina Zakavi, Mohammad Rafie Khorgami, Pedram Babaee, Alireza Babaeizadeh, Rahem Rahmati, Mina Felfeli, Elahe Meftah, Golnaz Houshmand, Fatemeh Abedpour, Amirfarjam Fazelifar, et al.

    Purpose: The utilization of stress perfusion cardiac magnetic resonance (CMR) in patients with cardiac implantable electronic devices (CIEDs) is still limited. Methods: The study was registered in the Prospective Register of Systematic Reviews (PROSPERO) with ID CRD42023457308. PubMed, Scopus, Embase, Web of Science, ProQuest, and CINAHL databases were searched using the Mesh and related terms of CMR imaging, stress, and CIEDs. Results: Out of the 1695 papers we found, eight met our inclusion criteria. We reviewed the included studies and provided a concluding remark concerning (a) image quality; (b) CMR compatibility, scanner, and safety; (c) device protocols and exclusion criteria; (d) vasodilator choices, effects, and safety; and (e) clinical outcomes. Conclusion: This study has demonstrated a positive trend in the utilization of stress CMR in MR‐conditional devices. However, the review has identified multiple research gaps that warrant further investigation.

  • Open Access

    A Middle‐Aged Man With Pulseless VT and Dual Pathology: Anomalous Left Main Coronary Artery From Right Coronary Cusp With Transseptal Course and Underlying Dilated Cardiomyopathy

    by Amir Heidari, Enssieh Hashemi, Mehrdad Jafari Fesharaki, Golnaz Houshmand, Roghaye Ghiasvand‐Mohammadkhani

    Anomalous aortic origin of a coronary artery from the opposite sinus (AOCAOS) is a rare variety of coronary artery anomalies. Left main coronary artery (LMCA) arising from right coronary cusp (RCC) with a transseptal course is an uncommon variant that may not be as benign as previously thought. The coexistence of AOCAOS with dilated cardiomyopathy (DCM) is exceptionally rare and presents diagnostic and therapeutic challenges. Herein, we present a 43‐year‐old man with a history of Type 2 diabetes mellitus and chronic substance use who was admitted after successful resuscitation from pulseless ventricular tachycardia (VT). Initial workup revealed severely reduced left ventricular ejection fraction (LVEF) of 20% on echocardiography. Invasive coronary angiography demonstrated anomalous origin of the LMCA from the RCC. Cardiac magnetic resonance (CMR) confirmed the diagnosis of DCM with no evidence of fibrosis, and coronary computed tomography angiography (CCTA) delineated a transseptal course of the anomalous LMCA. The patient was managed medically for heart failure and underwent cardiac resynchronization therapy defibrillator (CRT‐D) implantation for primary prevention of sudden cardiac death. At 3‐month follow‐up, he showed significant clinical improvement. This case underscores the importance of a comprehensive diagnostic approach in sudden cardiac death survivors and highlights that transseptal AOCAOS may not be benign when associated with cardiomyopathy. Coronary CTA and CMR are essential tools for complete evaluation.